Post Operative Complications Associated with Preoperative use of Clopidogrel in Patients Undergoning Coronary Artery Bypass Surgery
Muhammad Shahid, Mujahid Ul Islam, Imtiaz Ahmad, Bahauddin Khan, Faizan Ahmad Ali, Naseer Ahmed, Marib Ghulam Rasool Malik, Shah Arif
3154
ABSTRACT
Background: Majority of the patients presenting for
coronary artery bypass surgery are preoperatively on clopidogrel and aspirin
i.e., Dual antiplatelets therapy (DAPT) because of high incidence of left main
stem disease, acute coronary syndrome and diffuse coronary artery disease. Preceding
coronary stenting and coming from far flung areas even from other countries
with poor socioeconomic status contributes to continuation of DAPT till
surgery.
The
main objective of the study was to evaluate hospital complications like chest
tube output, re-explorations, blood, and blood product administration and
in-hospital mortality in patients who continued DAPT till 48 hours prior to
surgery versus those who continued DAPT until 48 to 120 hours before surgery.
Methods: Preoperative history, perioperative and
postoperative data of patients was gathered retrospectively from 1st
July to 31st December 2019 in a tertiary care hospital of Peshawar.
Total patients undergoing CABG Surgery were 223. From those 223 patients 192
patients were on DAPT. We than divided the 192 patients into two groups, Group
A and Group B. 102 patients (Group A) received clopidogrel plus aspirin until
48 hours before surgery, and 89 patients (Group B) continued clopidogrel 48 to
120 hours prior to surgery. Chest tube output, need for exploration,
in-hospital mortality, and blood or products transfusions among both groups
were compared.
Results: In terms of bleeding complications no
significant difference between the both groups with similar chest drainage in
the first 24 hours (602 ml and 609ml). In group A 33 patients received blood
transfusion compared to 25 patients from group B. There was no significant
difference in the amount of platelets given to group A (0.63 L) and to group B
was (0.60 L). On the other hand, Group, A received 1.08 L fresh frozen plasma
(FFPs) transfusion and group B 1.10 L respectively. Re-exploration was observed
in Group A and B as (3 vs 2). Mortality was observed in 7 patients from group A
and 2 from Group B.
Conclusions: Usage of Dual
antiplatelets therapy (DAPT) before surgery was an effective treatment method
for postoperative complication of bleeding. It was suggested that with proper
management with DAPT before surgery was planned is an effective and safe
treatment method..
Keywords: Cardiopulmonary surgery, Coronary bypass
grafting, hemoglobin, platelets, bleeding.